In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis.
about
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosisGATA4-dependent organ-specific endothelial differentiation controls liver development and embryonic hematopoiesisReprogramming cell fates by small molecules.Cell fate modification toward the hepatic lineage by extrinsic factors.Preclinical study of rAAV2-sTRAIL: pharmaceutical efficacy, biodistribution and safety in animals.Genetic tracing of hepatocytes in liver homeostasis, injury, and regeneration.Emerging advancements in liver regeneration and organogenesis as tools for liver replacement.Gene therapy approaches in the non-human primate model of Parkinson's disease.Engineering kidney cells: reprogramming and directed differentiation to renal tissues.In Vitro Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.Novel methods for the treatment of liver fibrosis using in vivo direct reprogramming technologyThe Effects and Possible Mechanisms of Puerarin to Treat Uterine Fibrosis Induced by Ischemia-Reperfusion Injury in Rats.In vivo reprogramming of hepatic myofibroblasts into hepatocytes attenuates liver fibrosis: back to the future?Stem Cells and Regeneration in the Digestive System: Keystone Meeting.CD29 is highly expressed on epithelial, myoepithelial and mesenchymal stromal cells of human salivary glands.Direct reprogramming of mouse fibroblasts into neural cells via Porphyra yezoensis polysaccharide based high efficient gene co-delivery.Specific Cell (Re-)Programming: Approaches and Perspectives.Resolution of organ fibrosis.
P2860
Q26742049-3AC0E86E-8770-4FBB-8FFC-89BDD367E158Q30840166-7CEC44B1-FDEB-4F5A-86ED-F5D4734564B6Q33628088-F82E5ABB-DABE-4014-8B69-7DFD981CB3CFQ38730766-DC9B4013-438B-4348-AAD2-ADA7036B4BBFQ38827170-C5B35C2F-01D5-4A36-B455-FBF3571204BAQ38854563-F2D3C1C5-B645-4C2D-9CAA-FB2982FE7FC8Q38984235-B52C73C8-20B9-4C13-BB7A-2C70D868F38AQ39107176-38BDF944-0CC5-48D2-ABCA-DBB3D2E8AD02Q39339921-E878384C-988C-4F0A-A182-397C9E3A87A4Q39410484-4E8284D7-BC40-4FC7-90BE-6C9850D38650Q41071961-D76901B9-4BB9-4F02-AB62-263E4127E043Q41085157-54214431-E857-4532-B1EB-ADA0B262BAD7Q42382415-E399BF6C-35A1-433E-9E26-AFBF79CD9B53Q44799874-2C2AEF0F-EA50-4AAB-BAF1-B2D360D66252Q46169666-330EA51E-1CAF-4FC3-974B-9A701BCA623CQ47109226-533EAA2A-01B1-47FD-ACF5-8E05C85BD1C1Q50085975-47EA256A-B12B-4B1E-B742-9C793AF01B9AQ52687459-BD090DB0-2AF1-4ED9-918F-0857C9D0A5A1
P2860
In Vivo Hepatic Reprogramming of Myofibroblasts with AAV Vectors as a Therapeutic Strategy for Liver Fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@en
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@nl
type
label
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@en
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@nl
prefLabel
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@en
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@nl
P2093
P2860
P1433
P1476
In Vivo Hepatic Reprogramming ...... c Strategy for Liver Fibrosis.
@en
P2093
Andrew A Grimm
Bernadette Y Hsu
Carlos U Corvera
Dirk Grimm
Ellen Wiedtke
Holger Willenbring
Julia G Bindman
Laure Dumont
Milad Rezvani
Regina Español-Suñer
P2860
P304
P356
10.1016/J.STEM.2016.05.005
P407
P577
2016-06-01T00:00:00Z